Clinical Trial Update: A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B [NA]

View source ↗

Summary

This clinical trial update notes a follow-up study of peginterferon alfa-2b combined with tenofovir disoproxil fumarate in chronic hepatitis B, with enrollment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Chronic Hepatitis B | NA | Status: ENROLLING_BY_INVITATION